Champions Oncology CSBR
NASDAQ CSBR
$5.08 +0.13 (+2.63%)
At close: Sep 17, 2026 · 4:00 PM EDT

Champions Oncology (CSBR) Net Equity Issued and Repurchased (2016)

Champions Oncology's (CSBR) quarterly Net Equity Issued and Repurchased came in at $4.3 million in Q3 2016.

Analysis

Champions Oncology (CSBR) Net Equity Issued and Repurchased (2016) Analysis & Trends

Champions Oncology (CSBR) has 1 years of Net Equity Issued and Repurchased data on file, last reported at $4.3 million in Q3 2016.

  • On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $4.3 million in Q3 2016; TTM through Apr 2017 was $4.3 million, a N/A change from a year earlier, with the FY2017 full-year figure at $4.3 million, changed N/A from the prior year.
  • Net Equity Issued and Repurchased for Q3 2016 stood at $4.3 million.
  • Across five years, Net Equity Issued and Repurchased topped out at $4.3 million in Q3 2016 and bottomed at $4.3 million in Q3 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn -
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn -
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn -
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn -
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn -
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn -
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn -
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn -
10 VivoSim Labs 1.37 Mn 1.37 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2016 4.34 Mn